Psoriasis
Disease State Hub
Featured
02/11/2025
Miranda Manier, BA
A recent study explores the long-term safety and efficacy of deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate-to-severe plaque psoriasis. Do you know the role TYK2 plays in...
02/11/2025
02/05/2025
Miranda Manier, BA
A phase 3 trial evaluating apremilast in children and adolescents with moderate-to-severe plaque psoriasis showed improvements in disease severity compared with placebo over 16 weeks.
02/05/2025
01/27/2025
Miranda Manier, BA
A recent study investigates the use of apremilast for pediatric patients with moderate-to-severe plaque psoriasis. Can you identify one of the key benefits of this treatment option for children? Take our...
01/27/2025
Interactive Features
02/11/2025
Miranda Manier, BA
A recent study explores the long-term safety and efficacy of deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate-to-severe plaque psoriasis. Do you know the role TYK2 plays in...
02/11/2025
01/27/2025
Miranda Manier, BA
A recent study investigates the use of apremilast for pediatric patients with moderate-to-severe plaque psoriasis. Can you identify one of the key benefits of this treatment option for children? Take our...
01/27/2025
09/10/2024
When managing patients with psoriatic arthritis who do not respond to tumor necrosis factor inhibitors, clinicians must consider several factors before changing their treatment. Think you know what they...
09/10/2024
05/21/2023
According to the National Psoriasis Foundation Medical Board, what diet is strongly recommended for patients with psoriasis with overweight and obesity?
05/21/2023
04/15/2023
Do you know how many cases of psoriasis begin in a patient’s pediatric years? Take our pop quiz to find out!
04/15/2023
Clinical Insights
09/04/2024
In this Q and A, Valentina Celoria, MD, discusses the relationship between the human microbiome and psoriatic disease, as well as what this relationship may mean for future treatments.
09/04/2024
09/18/2022
Consultant360 spoke with Zenas Yiu, MBChB, PhD, NIHR Clinical Lecturer in Dermatology at the University of Manchester, about a recent study examining the relationship between psoriasis and risk of serious...
09/18/2022
01/20/2022
Adam Ford, BS, and April Armstrong, MD, MPH, answer our questions about the role of diet in psoriatic disease and the importance of dietary recommendations for individuals with psoriasis and/or psoriatic...
01/20/2022
10/18/2021
Alexander Egeberg, MD, PhD, discusses his latest research, which suggests that 1 in 4 patients with psoriasis also has psoriatic arthritis.
10/18/2021
06/15/2021
Alan Menter, MD, from Baylor Medical Center, discusses the comorbidity profile of psoriasis.
06/15/2021
